NCT06788912 2026-03-31
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06043323 2026-03-12
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05896228 2026-03-11
Iber-KDd
University of Miami
Phase 2 Recruiting
NCT05842044 2025-09-05
No-PAIN
University of Miami
Phase 2 Recruiting